Workflow
Argan(AGX)
icon
搜索文档
Steven Cress Reviews His Top 10 Stocks For 2025
Seeking Alpha· 2025-12-17 06:20
2025年市场回顾与量化选股表现 - 2025年市场情绪多变,呈现“风险偏好”与“避险”主题并存的格局,科技和通信服务等风险偏好板块与黄金、白银等传统避险资产均表现强劲[8] - 市场波动主要源于美国贸易政策,特别是中美贸易战升级,导致标普500指数最大回撤达15%,并引发对电动汽车、电池制造商和半导体行业的担忧[13][14][16] - 量化系统选出的2025年十大股票组合表现卓越,自1月9日至12月10日回报率达45.68%,远超同期标普500指数17.6%的涨幅[34] - 历史数据显示,在市场出现15%的回调时买入标普500指数并持有两年,平均回报率接近50%;若同期买入量化系统“强力买入”评级股票,两年回报率可达117%[19][20] - 量化选股策略的核心是专注于基本面强劲的公司,当市场因情绪驱动而下跌时,这类公司会出现被错杀的机会,随后当市场回归基本面时会产生巨大上涨空间[21][36][37] 行业与宏观经济动态 - 2025年美元走弱,美元指数年内下跌约9.5%,资金从美元和美国国债流出,转向黄金等资产,中国央行也在增持黄金作为避险[9][10] - 截至2025年末,科技板块年内上涨27%,但近期防御性板块走强,过去一个月必需消费品上涨2.3%,医疗保健上涨3.3%[12][17] - 人工智能主题推动市场估值分化,“美股七巨头”基于远期收益的市盈率为31倍,而标普500指数中其余493只股票的市盈率仅为22倍,七巨头市值占标普500总市值的35%[29][30] - 为支持人工智能发展,超大规模云计算公司资本支出大幅增加,远超十年前水平[31] - 美联储在2025年下半年降息三次,主要出于对劳动力市场疲软的担忧,尽管通胀仍具粘性[23][24][25] - 美联储点阵图显示,未来预期的降息次数减少,市场预计利率将维持在当前水平附近,除非出现“黑天鹅”事件[26][27] 2025年十大股票详细分析 - **Credo Technology (CRDO)**:市值280亿美元,属于信息技术板块,自1月9日起股价上涨116%[48][49]。公司专注于高速连接解决方案,第二季度营收因新的AI连接支柱而同比增长272%[49]。其增长评级为A+,远期盈利增长率预计为78%,市盈增长比率(PEG)为0.7,较行业有55%的折价[51]。过去90天内,有10次分析师上调盈利预期,无下调[52] - **Celestica (CLS)**:市值约400亿美元,自1月9日起股价上涨240%[53][54]。公司为超大规模数据中心制造商复杂硬件平台,第三季度营收同比增长28%,每股收益同比增长52%,远期每股收益增长率为51%[54]。其PEG较行业有45%的折价,过去90天内14位分析师上调预期,无下调[54] - **OppFi (OPFI)**:市值9.27亿美元,是一家专业金融平台[57]。公司远期息税前利润(EBIT)增长率为84%,营运现金流同比增长22%,持有3.78亿美元营运现金流,市盈率7倍,较行业有41%的折价[58]。该股在贸易战和衰退担忧期间大幅下跌,但基本面保持完好,目前已恢复“买入”评级[56][58] - **Urban Outfitters (URBN)**:市值70亿美元,维持“强力买入”评级[59]。公司远期每股收益增长率为23%,远超行业平均的6.74%[64]。尽管年内股价已大幅上涨,其估值、增长、盈利能力、动量和分析师修正评级均与行业持平或更优[62] - **Argan (AGX)**:尽管估值评级为F,但该股自1月9日起上涨111%[66][68]。公司增长评级为A,盈利能力评级为A,专注于大型电力和工业项目的工程建造,是数据中心能源需求激增的受益者[67][68]。其远期营收增长率为28%,远期每股收益增长率为59%,较行业有628%的溢价,并拥有每股22美元的现金[69] - **PayPal Holdings (PYPL)**:市值570亿美元,年内股价下跌30%[70][71]。公司股本回报率为24%,股本回报率增长为10%,较行业有300%的溢价[71]。远期每股收益增长率为13.8%,较行业有近30%的溢价[74]。基于市盈率(PEG)和远期市盈率(11倍 vs 行业12.3倍),估值仍低于行业[76]。过去90天内38位分析师上调营收预期,仅2位下调[72] - **Intapp (INTA)**:市值35.2亿美元,年内股价下跌32%[77]。公司提供AI驱动和云端软件,近期分析师情绪转好,过去90天内10位分析师上调盈利预期,无下调[78] - **Brinker (EAT)**:自1月9日起股价微跌2.27%[79]。公司因管理层业绩指引弱于预期和动能放缓,于10月2日评级下调为“持有”,但其远期每股收益长期复合年增长率仍达14%[81] - **DXP Enterprises (DXPE)**:自1月9日起股价上涨23%,近期评级从“卖出”回升至“持有”[82][83]。该股评级波动部分由于覆盖分析师较少,个别分析师下调预期对评级影响较大[83][87] - **Stride (LRN)**:目前为投资组合中唯一的“卖出”评级,主要因动能和分析师修正评级不佳(分别为F和D-)[91]。公司增长和估值的一些常规指标仍具吸引力,但第三季度业绩未达预期以及技术推广问题导致学生退学率升高,严重影响了股价和情绪[92][93][96]。过去90天内无分析师上调预期,4位下调预期[97] 量化投资方法论 - 量化“强力买入”评级基于股票在价值、增长、盈利能力、动量和每股收益修正五个因素上的集体强势表现[47] - “持有”评级并不意味着“卖出”,它表明尽管某些方面(如估值)可能不具吸引力,但公司在其他基本面因素上仍有优势,值得继续持有[40][65] - 投资组合采用买入并持有策略,年初选定的十只股票全年保持不变,旨在通过长期持有基本面强劲的公司来超越市场[45][46] - 历史业绩显示,该策略持续跑赢大盘,例如2024年的十大股票组合若持有至今,回报率达356%,远超“美股七巨头”103%和标普500指数47.79%的涨幅[39]
Argan: Expanding Backlog And The Power Demand Supercycle Support A Buy Rating (NYSE:AGX)
Seeking Alpha· 2025-12-10 21:18
I last covered Argan ( AGX ) in September with a buy rating, and the stock is up ~60% since then. The stock has given up some of the gains in the recent weeks, especially postI have over 15 years of experience investing and have provided research services to mid-sized hedge funds with assets under management between $100 and $500 million. I also have had a brief stint as a sell-side analyst. I am now focusing primarily on managing my own money and my purpose here is to share my views and benefit from the in ...
Argan: Expanding Backlog And The Power Demand Supercycle Support A Buy Rating
Seeking Alpha· 2025-12-10 21:18
I last covered Argan ( AGX ) in September with a buy rating and the stock is up ~60% since then. The stock has given up some of the gains in the recent weeks, especiallyI have over 15 years of experience investing and have provided research services to mid-sized hedge funds with assets under management between $100 and $500 million. I also have had a brief stint as a sell-side analyst. I am now focusing primarily on managing my own money and my purpose here is to share my views and benefit from the insights ...
Roche breast cancer pill cuts risk of disease recurrence by 30% in trial
Reuters· 2025-12-10 21:16
Roche said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared with standard endocrine therapy, in what it said marked the first big advan... ...
Argan, Inc.: No Signs Of Structural Weakness (NYSE:AGX)
Seeking Alpha· 2025-12-10 20:36
I focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-term. Ultimately, I aim to identify companies with solid fundamentals, sustainable competitive advantages, and growth potential.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the compa ...
Argan, Inc.: No Signs Of Structural Weakness
Seeking Alpha· 2025-12-10 20:36
投资理念与方法 - 投资策略采用自下而上的基本面分析 专注于挖掘个股的基本面优势与劣势 [1] - 投资期限以中长期为主 旨在寻找基本面扎实、拥有可持续竞争优势和增长潜力的公司 [1] - 投资组合构建结合长期投资与短期做空 以发掘阿尔法机会 [1]
Argan: Q3 Volatility Sets Up A Compelling Opportunity (NYSE:AGX)
Seeking Alpha· 2025-12-10 20:20
文章核心观点 - 作者专注于研究科技、工业和综合企业集团等行业,并偏好基本面强劲、具有长期发展潜力的公司 [1] - 作者通过结合财务分析和深度写作,剖析公司的故事、战略和财务细节,旨在提供对公司未来表现的见解,并帮助读者更好地理解市场 [1] 作者背景与研究方法 - 作者拥有研究经验,致力于深入理解和阐释金融世界的细节 [1] - 研究方法融合了财务数据分析与叙述性写作 [1]
Argan: Q3 Volatility Sets Up A Compelling Opportunity
Seeking Alpha· 2025-12-10 20:20
文章核心观点 - 作者专注于研究科技、工业和综合企业集团等行业,偏好并长期看好基本面强劲的公司 [1] - 作者通过结合财务分析与深度写作,剖析公司的故事、战略和财务细节,以提供对公司未来表现的见解,并帮助市场参与者更好地理解市场 [1] 作者背景与研究方法 - 作者拥有研究经验,致力于深入理解和阐释金融世界的细节 [1] - 研究方法融合了财务数据分析与叙述性写作 [1]
Argan, Inc.: Record Backlog Drives Continued Earnings Momentum (NYSE:AGX)
Seeking Alpha· 2025-12-10 19:36
With years of investing experience in the financial markets, I have honed my skills in identifying and capitalizing on investment opportunities across diverse sectors. My investment approach is based on fundamental analysis of stocks, focusing on companies with a strong competitive moat, consistent growth in free cash flow, and a track record of robust financial performance.My investment philosophy is rooted in long-term, fundamental investing. I steer clear of short-term trading tactics and options, believ ...
Argan, Inc.: Record Backlog Drives Continued Earnings Momentum
Seeking Alpha· 2025-12-10 19:36
With years of investing experience in the financial markets, I have honed my skills in identifying and capitalizing on investment opportunities across diverse sectors. My investment approach is based on fundamental analysis of stocks, focusing on companies with a strong competitive moat, consistent growth in free cash flow, and a track record of robust financial performance.My investment philosophy is rooted in long-term, fundamental investing. I steer clear of short-term trading tactics and options, believ ...